Streetbeat News

Stock Prices

GELLY

ZK

Zhejiang Geely Holding Group (OTC:GELLY) has entered the global top 10 for auto sales in Q1 2024, marking a first for a Chinese carmaker. Geely sold 730,000 vehicles, a 27% year-on-year growth, driven by strong electric vehicle exports. The company surpassed Mercedes-Benz and BMW in the rankings. Geely's EV arm, Zeekr Intelligent Technology Holding Limited (NYSE:ZK), aims to double car deliveries in 2024.

Portfolio Pulse from Benzinga Neuro

May 28, 2024 | 9:36 am

TSLA

Jim Chanos criticizes Elon Musk's recruitment efforts for his AI venture, xAI, while highlighting the irony of Musk's claims about Tesla being an AI/robotics company. This comes ahead of Tesla's annual shareholder meeting, where Musk's controversial compensation plan is up for reconsideration.

Portfolio Pulse from Shanthi Rexaline

May 28, 2024 | 9:34 am

BNBUSD

Cristiano Ronaldo is set to launch his fourth NFT collection on Binance despite being involved in a $1 billion lawsuit. The collection will be available on May 29 and will feature moments from Ronaldo's career. The lawsuit accuses Ronaldo of promoting unregistered securities through Binance.

Portfolio Pulse from Aniket Verma

May 28, 2024 | 9:29 am

CNF

CNFinance has increased its share repurchase authorization to $30 million. As of May 27, 2024, the company has already repurchased approximately $18.5 million of its ADSs.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:30 am

ORDI

SOL

The Solana-based CAT memecoin has crashed after its creators were accused of hacking a crypto influencer's account and manipulating the coin's price. The coin's value dropped by 70% in the last 24 hours.

Portfolio Pulse from Aniket Verma

May 28, 2024 | 8:18 am

FUTU

Futu Holdings reported significant growth in Q1 2024, with a 7% YoY increase in daily average revenue trades, a 23.5% increase in paying clients, and an 8.9% increase in margin financing and securities lending balance.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:14 am

FUTU

Futu Holdings reported strong Q1 2024 operational results with significant year-over-year growth in client assets, trading volume, and user base. Total client assets increased by 11.2% YoY to HK$517.9 billion, and total trading volume rose by 9.5% YoY to HK$1.3 trillion.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:12 am

FUTU

Futu Holdings reported significant growth in Q1 2024, with a 23.5% YoY increase in paying clients, a 15.4% YoY increase in registered clients, and a 12.3% YoY increase in total users.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 8:10 am

NVS

Novartis reported significant Phase III data for Fabhalta (iptacopan) in treating C3 glomerulopathy (C3G), showing a 35.1% reduction in proteinuria compared to placebo. The drug also showed numerical improvement in eGFR over 6 months and a favorable safety profile. C3G is a rare kidney disease with no current treatments, and Fabhalta targets its underlying cause.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:51 am

NVS

Novartis' Phase III data for atrasentan shows a significant reduction in proteinuria, enhancing its IgA Nephropathy (IgAN) portfolio. The ALIGN study demonstrated a 36.1% reduction in proteinuria with atrasentan plus supportive care compared to placebo. This positions Novartis to address the needs of patients with this rare kidney disease.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:49 am